Newstead Jennifer

Meta CLO Jennifer Newstead sold 907 shares at $645.77 on 2025-05-13; holds 24.7K shares post-transaction.

Jennifer Newstead, Meta's Chief Legal Officer, sold 907 shares for a total value of $585,713.39, reducing her holdings by 3.5% from the prior level. The transaction occurred at $645.77 per share, which was 12.6% above the current market price of $643.88. Her cross-ticker track record shows 20 prior open-market sells with a 90-day well-timed rate of 90.00%, but at Meta specifically, she has completed 5 prior sells with no measurable 90-day outcomes yet—making this ticker-specific timing assessment inconclusive. The sale occurs in a window where Meta shares are up 23.5% over 30 days and down 12.6% over 90 days, within a 52-week range of $453.41–$736.67, with the company posting strong fundamentals: $42.3B in latest quarterly revenue, $16.6B in net income, and 21.9% annual revenue growth.

META CLO Jennifer Newstead sold 921 shares at $592.52 on 2025-05-06 ($545.7K), holding 25.7K post-sale.

Jennifer Newstead, Chief Legal Officer, sold 921 shares (-3.5% of pre-transaction holdings) at $592.52 on May 6, 2025, leaving a position of 25,656 shares. Her cross-ticker track record shows 20 prior sells with a 90-day well-timed rate of 80%, suggesting a history of exiting positions before declines; however, at META specifically, none of her 5 prior sales have yet reached the 90-day measurement window for timing assessment. The stock has since appreciated to $598.01 (+17.2% over 30 days) from her sale price, moving within the 52-week range of $451.96–$736.67. Meta's fundamentals remain strong with $42.3B quarterly revenue, $16.6B net income, and +21.9% annual growth, supported by a 24.30 P/E multiple. The sale reflects a modest reduction in a substantial personal stake and does not indicate a significant directional shift in her holdings at the company.

Meta CLO Newstead sold 921 shares at $545.17 on 2025-04-29; stock now at $572.21, down 17.0% in 90 days.

Jennifer Newstead, Chief Legal Officer, sold 921 shares at $545.17, reducing holdings from 27.5K to 26.6K shares (a -3.3% reduction). The sale occurred when META was trading below its 52-week high by 22.3%, and the stock has since declined 17.0% over 90 days. Across Newstead's cross-ticker open-market history, her prior sells have been well-timed at a 70.00% rate with a -4.8% average 90-day return, suggesting a pattern of selling before declines. However, at META specifically, her 5 prior trades show mixed results: the most recent measurable outcome (2025-03-25 sale) yielded a -15.0% 30-day return, while earlier sales at this ticker have not yet produced measurable 90-day outcomes. The routine nature of the position reduction and the company's strong fundamentals (revenue growth of 21.9%, P/E of 23.25) indicate this is a modest, non-structural position adjustment rather than a signal of fundamental concern.

CLO Jennifer Newstead sells 921 META shares at $543.39; stock down 9.8% in 30 days, -25.8% from 52-week high

Chief Legal Officer Jennifer Newstead sold 921 shares of Meta for $500.5K on 2025-04-08, reducing her holdings from 30.3K to 29.3K shares (-3.0%). The sale occurred at $543.39 per share, and Meta's stock has since declined 9.8% over the subsequent 30 days and 11.3% over 90 days. Newstead's cross-ticker sales track record shows a 50.00% well-timed rate at the 90-day mark (average 90d return +3.3%), but at Meta specifically, her 5 prior sales show no measurable 90-day outcomes yet. The company's fundamentals remain solid: $40.6B in latest quarterly revenue, $15.7B net income, and 21.9% annual revenue growth, with a P/E of 22.20. The timing context—sell at $543.39 followed by price decline—warrants observation given the stock's broader 25.8% retreat from its 52-week high, though this single transaction in isolation cannot be isolated from broader market conditions or tax/portfolio management considerations.

Chief Legal Officer Jennifer Newstead sold 921 META shares at $570.66 on 2025-04-01 for $525,577.86; stock down 27.8% from 52-week high.

Jennifer Newstead, Chief Legal Officer of Meta Platforms, sold 921 shares for $525,577.86 at $570.66 on 2025-04-01, reducing her holdings to 30,261 shares (a 3.0% reduction). The transaction occurred as META stock has declined significantly, trading 27.8% below its 52-week high and down 16.9% over the past 30 days. At the same-ticker level, Newstead has executed five consecutive sales in March and April 2025; of these, measurable 30-day outcomes for the two earliest trades show declines of 17.4% and 9.5%, indicating sales that preceded downward price movement. Her cross-ticker track record across 20 prior open-market sells shows a 37.50% well-timed rate, though this provides limited predictive power for timing within a single stock. The timing of this April sale—in a period of sustained weakness—does not contradict her historical pattern, but the absence of measurable longer-term outcomes for her recent META sales limits conclusions about directional accuracy.

Meta CLO Jennifer Newstead sells 921 shares for $577.5K at $627.05; recent pattern shows three sales in 14 days

Newstead sold 921 shares at $627.05 on 2025-03-25, reducing holdings by 2.9% to 31,182 shares. This follows two additional sells within the prior two weeks (2025-03-18 and 2025-03-11), suggesting a concentrated disposition pattern rather than a one-off event. At current price of $602.58, the stock is -18.2% from its 52-week high of $736.67 and down 8.4% over the past 30 days, though Meta's fundamentals remain strong with $40.6B revenue, $15.7B net income, and 21.9% annual revenue growth. Across her cross-ticker history, Newstead's prior sells showed a 25.00% well-timed rate with average 90-day returns of +8.4%, but her prior five trades specifically at META have not yet produced measurable outcomes beyond 30 days.

Meta CLO Jennifer Newstead sold 921 shares at $600.25 (down -20.4% from 52-week high); cross-ticker track record shows 25.00% well-timed sell rate.

Jennifer Newstead, Chief Legal Officer of Meta Platforms, Inc., sold 921 shares for $552,830.25 on 2025-03-18, reducing her holdings by -2.8% to 32,103 shares. The sale occurred at $600.25 per share, well below the 52-week high of $736.67 and 18.2% below the 30-day moving context. Across her open-market history across all tickers, Newstead has executed 20 prior sells with a 25.00% well-timed rate (90-day outcomes where the stock fell after her sale), and an average 90-day return of +8.5%, indicating her prior sells at other tickers have generally preceded price appreciation rather than declines. At Meta specifically, Newstead has completed five prior trades, all sells, clustered tightly between 2025-02-11 and 2025-03-11, though outcomes at the 90-day mark remain immeasurable for the three most recent sales. The pattern of repeated sales in a compressed timeframe, combined with current price weakness relative to the 52-week range, warrants monitoring for additional context on the motivation and whether this represents portfolio management activity or reflects operational decisions at the company.

Meta CLO Jennifer Newstead sold 921 shares at $595.00 on 2025-03-11; price has fallen 19.8% from 52-week high.

Newstead sold 921 shares at $595.00 on 2025-03-11, reducing her holdings by 2.7% to 33,024 shares. The stock has declined 19.8% from its 52-week high of $736.67 and is currently trading at $590.64, down 17.9% over the past 30 days. Her cross-ticker track record shows an average 90-day return of +9.8% following prior sells, with a 12.50% well-timed rate, indicating her historical sells have not captured downside moves. However, at Meta specifically, her 5 prior open-market sales show an emerging pattern: two recent sales (2025-02-11 and 2025-02-04) recorded 30-day declines of -17.2% and -10.6% respectively, though longer-term outcomes remain unmeasured. This sale occurs during a period of significant price weakness, warranting monitoring of whether the pattern at this ticker diverges from her cross-ticker history.

CLO Jennifer Newstead sold 921 META shares at $644.00 on 2025-03-04; stock down 14.8% from 52-week high, recent 30-day decline -10.8%.

Jennifer Newstead, Meta's Chief Legal Officer, sold 921 shares for $593,124.00, reducing her holdings by 2.6% to 33,945 shares. The sale occurred as the stock traded near recent weakness: META is down 10.8% over the past 30 days and 14.8% below its 52-week high of $736.67, though up marginally 0.7% over 90 days. Her prior trades at Meta show no well-timed outcomes (0 of 0 prior sales had positive timing at the 90-day mark), and her cross-ticker sell track record reflects mixed results: 20 prior sells posted an average 90-day return of +10.5%, with a 0.00% well-timed rate, meaning those sales were typically followed by stock appreciation. Her recent trading pattern at Meta is notable: four of five prior sales occurred within the last month (2025-01-28 through 2025-02-25), with the most recent pre-filing sale on 2025-02-25, just 7 days before this transaction. The frequency and concentration of dispositions warrant observation of any accompanying disclosures or communications regarding strategic direction or capital allocation.

Meta CLO Jennifer Newstead sold 921 shares at $665.75 on 2025-02-25, reducing holdings to 34.9K shares; stock now -10.6% from 52-week high.

Jennifer Newstead, Meta's Chief Legal Officer, executed a sale of 921 shares at $665.75, reducing her post-transaction holdings to 34,866 shares (a -2.6% reduction). The transaction occurred when META was trading near its 52-week highs but has since declined 10.6% from its peak of $736.67. Her prior five trades at Meta span seven days in late January and February 2025, establishing a pattern of frequent open-market sales. Notably, her cross-ticker track record shows a 90-day well-timed rate of 0.00% across 20 prior sales—indicating her sales have not historically preceded declines—yet the timing context here differs: Meta's 14.6% gain over 90 days suggests the sell occurred during recent strength, and the subsequent -2.4% decline over 30 days provides only limited post-transaction evidence.